<doc>
  <docmeta id="113s136is">
    <bill congress="113" type="s" number="136" version="is"/>
    <revision size="8115" annotations="0" id="7" commit-time="2013-04-18T23:24:08+00:00" committer="favila" doc="113s136is/7.xml" status="complete">
      <description/>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-Senate" public-private="public">
	<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. 136</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20130124" legis-day="20130103">January 24
			 (legislative day, January 3), 2013</action-date>
			<action-desc>
        <sponsor name-id="S299">Mr. Vitter</sponsor> introduced
			 the following bill; which was read twice and referred to the
			 <committee-name committee-id="SSFI00">Committee on
			 Finance</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend the Internal Revenue Code of 1986 to provide a
		  Federal income tax credit for certain stem cell research
		  expenditures.</official-title>
	</form>
	<legis-body>
		<section id="S1" section-type="section-one">
      <enum>1.</enum>
      <header>Short
			 title</header>
      <text display-inline="no-display-inline">This Act may be cited as
			 the <quote>
          <short-title>Ethical Stem Cell Research Tax
			 Credit Act of 2013</short-title>
        </quote>.</text>
		</section>
    <section id="idFE87EEFF70A34E108F2A98409D680BB1">
      <enum>2.</enum>
      <header>Credit for
			 ethical stem cell research</header>
			<subsection id="id274280557C9849DAB436B095B036ECDF">
        <enum>(a)</enum>
        <header>In
			 general</header>
        <text>
          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/ch:1/sch:A/pt:IV/spt:D">Subpart D of part IV of subchapter A of chapter 1 of the
			 Internal Revenue Code of 1986</cato:entity-ref> is amended by adding at the end the following new
			 section:</text>
				<quoted-block display-inline="no-display-inline" id="id8BC6D2ED98634406BDD79FEDCAC160FA" style="OLC">
					<section id="ID719d1b938f8d4a999b0ea9350d35088f">
            <enum>45S.</enum>
            <header>Ethical stem
				cell research</header>
						<subsection id="ID0126c3df4c9a4148806e1e8d9b0391a0">
              <enum>(a)</enum>
              <header>Allowance of
				credit</header>
              <text>For purposes of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:38">section 38</cato:entity-ref>, in the case of an eligible
				taxpayer, the ethical stem cell research credit determined under this section
				for the taxable year shall be an amount equal to 30 percent of the qualified
				stem cell research expenses paid or incurred by the taxpayer during the taxable
				year.</text>
						</subsection>
            <subsection id="id994CD6936B514444B465D3C1C35B8FFE">
              <enum>(b)</enum>
              <header>Eligible
				taxpayer</header>
              <text>For purposes of this section, the term <term>eligible
				taxpayer</term> means any taxpayer that elects the application of this section
				for the taxable year.</text>
						</subsection>
            <subsection id="ID8e2c82f881ea4e979e3e823999680bb4">
              <enum>(c)</enum>
              <header>Qualified stem
				cell research expenses</header>
              <text>For purposes of this section—</text>
							<paragraph id="ID1d3a6193df1549df989efa0e0f82bbf5">
                <enum>(1)</enum>
                <header>In
				general</header>
                <text>The term <term>qualified stem cell research
				expenses</term> means expenses which are paid or incurred by the eligible
				taxpayer during the taxable year in carrying on basic and applied research to
				develop techniques for the isolation, derivation, production, testing, and
				human clinical use of stem cells that may result in improved understanding of
				or treatments for diseases and other adverse health conditions, no part of
				which may involve—</text>
								<subparagraph id="id164511D3D9B54980BE8958A8E2217201">
                  <enum>(A)</enum>
                  <text>the creation of a
				human embryo for research purposes,</text>
								</subparagraph>
                <subparagraph id="id44E5A0F825AB43BE9E5D652F68C3FA08">
                  <enum>(B)</enum>
                  <text>the destruction
				of or discarding of, or risk of injury to, a human embryo, or</text>
								</subparagraph>
                <subparagraph id="id4C74C6469CB14AEA8BB4736E8442E82F">
                  <enum>(C)</enum>
                  <text>the use of any
				stem cell, the derivation or provision of which would be inconsistent with
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:45S/ss:c/p:1/sp:A" proposed="true">subparagraph (A)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:45S/ss:c/p:1/sp:B" proposed="true">(B)</cato:entity-ref>.</text>
								</subparagraph>
              </paragraph>
              <paragraph id="IDfb14a75bdcb44dd48d43f31f02ebabe0">
                <enum>(2)</enum>
                <header>Human
				embryo</header>
                <text>The term <term>human embryo</term> means any organism not
				protected as a human subject under part 46 of title 45, Code of Federal
				Regulations (as in effect on the date of the enactment of this section) that is
				derived by fertilization, parthenogenesis, cloning, or any other means from one
				or more human gametes or human diploid cells.</text>
							</paragraph>
              <paragraph id="IDbfe5a93f62144d5d84793fa80af02854">
                <enum>(3)</enum>
                <header>Risk of
				injury</header>
                <text>The term <term>risk of injury</term> means subjecting a
				human embryo to risk of injury or death greater than that allowed for research
				on a fetus in utero under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                    <cato:entity-ref entity-type="act" value="Public Health Service Act/s:498/ss:b">section 498(b) of the Public Health Service Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/289g/b">42
				U.S.C. 289g(b)</cato:entity-ref>)</cato:entity> (as in effect on the date of the enactment of this section) and
				section 46.204(b) of title 45, Code of Federal Regulations (as so in
				effect).</text>
							</paragraph>
            </subsection>
            <subsection id="ID0931027ab9bc4371a67e23fa7878cdd4">
              <enum>(d)</enum>
              <header>Treatment of
				qualified stem cell research expenses</header>
							<paragraph id="id0F398E5C579A4C1BA9F6C5B1732806C0">
                <enum>(1)</enum>
                <header>In
				general</header>
                <text>Except as provided in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:45S/ss:d/p:2" proposed="true">paragraph (2)</cato:entity-ref>, any qualified stem
				cell research expenses for a taxable year to which an election under this
				section applies shall not be taken into account for purposes of determining the
				credit allowable under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:41">section 41</cato:entity-ref> for such taxable year.</text>
							</paragraph>
              <paragraph id="id5457B6C4955B4783B33B09625F96577D">
                <enum>(2)</enum>
                <header>Treated as base
				period research expenses</header>
                <text>Any qualified stem cell research
				expenses for any taxable year which are qualified research expenses (within the
				meaning of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:41/ss:b">section 41(b)</cato:entity-ref>) shall be taken into account in determining base
				period research expenses for purposes of applying <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:41">section 41</cato:entity-ref> to subsequent
				taxable years.</text>
							</paragraph>
            </subsection>
            <subsection id="id3BEF191A687C4E79964670A57F12944B">
              <enum>(e)</enum>
              <header>Special
				rules</header>
							<paragraph id="idA6A996245EB74C4C9956A4C88EFDFE67">
                <enum>(1)</enum>
                <header>Limitation</header>
                <text>No
				credit shall be allowed under this section with respect to any stem cell
				research conducted by a corporation to which an election under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:936">section 936</cato:entity-ref>
				applies.</text>
							</paragraph>
              <paragraph id="id8C4AB01AA668401F9059EDD4E60C5448">
                <enum>(2)</enum>
                <header>Aggregation of
				expenditures and allocations of credit</header>
                <text>Rules similar to the rules
				of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:41/ss:f/p:1, 2">paragraphs (1) and (2) of section 41(f)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:41/ss:g/p:1, 2">section 41(g)</cato:entity-ref> shall apply for
				purposes of this
				section.</text>
							</paragraph>
            </subsection>
          </section>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</subsection>
      <subsection id="idA323398CDA5A43018644404A01C29FA5">
        <enum>(b)</enum>
        <header>Credit allowed
			 as part of general business credit</header>
        <text>
          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:38/ss:b">Section 38(b) of the Internal Revenue Code
			 of 1986</cato:entity-ref> is amended by striking <quote>plus</quote> at the end of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:38/ss:b/p:35">paragraph
			 (35)</cato:entity-ref>, by striking the period at the end of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:38/ss:b/p:36">paragraph (36)</cato:entity-ref> and inserting
			 <quote>, plus</quote>, and by adding at the end the following new
			 paragraph:</text>
				<quoted-block display-inline="no-display-inline" id="idB20646D77DC34C04A7D7AB4F7D0F44BE" style="OLC">
					<paragraph id="idD3B845F19366478AA3977887B97EB19D">
            <enum>(37)</enum>
            <text>the ethical stem
				cell research credit determined under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:45S/ss:a" proposed="true">section
				45S(a)</cato:entity-ref>.</text>
					</paragraph>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</subsection>
      <subsection id="idD4ECBB5A3F8B489ABB43FB6538AAE6C3">
        <enum>(c)</enum>
        <header>Denial of
			 double benefit</header>
				<paragraph id="idC41CDB4C87D640E38A7823BBF26DD1FB">
          <enum>(1)</enum>
          <header>Technical
			 amendment</header>
          <text>The second <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:280C/ss:g">subsection (g) of section 280C of the
			 Internal Revenue Code of 1986</cato:entity-ref>, as added by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Patient Protection and Affordable Care Act/s:1401/ss:b">section 1401(b) of the Patient
			 Protection and Affordable Care Act</cato:entity-ref>, is redesignated as <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:280C/ss:i">subsection (i)</cato:entity-ref>.</text>
				</paragraph>
        <paragraph id="idD0B89CE8BA8F40EC8B5E7281B58844C5">
          <enum>(2)</enum>
          <header>In
			 general</header>
          <text>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:280C">Section 280C of the Internal Revenue Code of 1986</cato:entity-ref>, as
			 amended by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Ethical Stem Cell Research Tax Credit Act of 2013/s:2/ss:c/p:1" proposed="true">paragraph (1)</cato:entity-ref>, is further amended by adding at the end the following
			 new subsection:</text>
					<quoted-block display-inline="no-display-inline" id="id31CEE631237B4786840F3C9BEBFE7C01" style="OLC">
						<subsection id="id4A5EDF1825754027B6687ACF7D730E4F">
              <enum>(j)</enum>
              <header>Ethical stem
				cell research credit</header>
							<paragraph id="ID0a9dda9d1a8b4f5a8aa20a28f5107e03">
                <enum>(1)</enum>
                <header>In
				general</header>
                <text>No deduction shall be allowed for that portion of the
				qualified stem cell research expenses (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:45S/ss:c/p:1" proposed="true">section 45S(c)(1)</cato:entity-ref>)
				otherwise allowable as a deduction for the taxable year which is equal to the
				amount of the credit determined for such taxable year under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:45S/ss:a" proposed="true">section
				45S(a)</cato:entity-ref>.</text>
							</paragraph>
              <paragraph id="IDad93f5f579f54bf7ae16abf39394d863">
                <enum>(2)</enum>
                <header>Similar rule
				where taxpayer capitalizes rather than deducts
				expenses</header>
                <text>If—</text>
								<subparagraph id="ID5ebe7a9753a74a7d8ebdd1c341da7b60">
                  <enum>(A)</enum>
                  <text>the amount of the
				credit determined for the taxable year under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:45S/ss:a" proposed="true">section 45S(a)</cato:entity-ref>, exceeds</text>
								</subparagraph>
                <subparagraph id="IDc8744330994043df9d392a534f3699d9">
                  <enum>(B)</enum>
                  <text>the amount
				allowable as a deduction for such taxable year for qualified stem cell research
				expenses (determined without regard to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:280C/ss:j/p:1" proposed="true">paragraph (1)</cato:entity-ref>),</text>
								</subparagraph>
                <continuation-text continuation-text-level="paragraph">the amount
				chargeable to capital account for the taxable year for such expenses shall be
				reduced by the amount of such excess.</continuation-text>
              </paragraph>
              <paragraph id="ID98a8db84b16a410db4a25eae512e0228">
                <enum>(3)</enum>
                <header>Controlled
				groups</header>
                <text>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:280C/ss:b/p:3">Paragraph (3) of subsection (b)</cato:entity-ref> shall apply for purposes
				of this
				subsection.</text>
							</paragraph>
            </subsection>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
      </subsection>
      <subsection id="id7CB8D6C7B0744708BB0F9A45C29B9D33">
        <enum>(d)</enum>
        <header>Clerical
			 amendment</header>
        <text>The table of sections for <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/ch:1/sch:A/pt:IV/spt:D">subpart D of part IV of
			 subchapter A of <external-xref legal-doc="usc-chapter" parsable-cite="usc-chapter/26/1">chapter 1</external-xref> of the Internal Revenue Code of 1986</cato:entity-ref> is amended by
			 adding at the end the following new item:</text>
				<quoted-block display-inline="no-display-inline" id="id5F071610B7F740E9B7838ACAD7E0C233" style="OLC">
					<toc regeneration="no-regeneration">
						<toc-entry level="section">Sec. 45S. Ethical stem cell
				research.</toc-entry>
					</toc>
					<after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</subsection>
      <subsection commented="no" display-inline="no-display-inline" id="idDE44CB7A478F4792B1CCD82F64F0BCFC">
        <enum>(e)</enum>
        <header>Effective
			 Date</header>
        <text>The amendments made by this section shall apply to amounts
			 paid or incurred after the date of the enactment of this Act.</text>
			</subsection>
    </section>
  </legis-body>
</bill>
</doc>